Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) P/S ratio
As of 5 November 2026, Doximity, Inc. (DOCS) trades at a P/S ratio of 9.0×. Over the past ten years it has ranged from 5.2× (May 2026) to 57.8× (October 2021); the current reading is higher than 14% of that period. That is above the Health Information Services industry median of 1.8× and above the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2026 | 6.8× | (64.45%) |
| FY2025 | 19.0× | 79.93% |
| FY2024 | 10.6× | (29.23%) |
| FY2023 | 14.9× | (39.78%) |
| FY2022 | 24.8× | 30.16% |
| FY2021 | 19.0× | 0.00% |
| FY2020 | 19.0× | 0.00% |
| FY2019 | 19.0× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 7.7× | 32.51% |
| Jun 2026 | 5.8× | (14.52%) |
| Mar 2026 | 6.8× | (48.09%) |
| Dec 2025 | 13.0× | (41.10%) |
| 23 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 0.9× |
| PRVA Privia Health Group, Inc. compare | 1.2× |
| WAY Waystar Holding Corp. compare | 4.4× |
| HQY HealthEquity, Inc. compare | 6.3× |
| SDGR Schrodinger, Inc. compare | 8.1× |
| TEM Tempus AI, Inc. compare | 8.5× |
| DOCS Doximity, Inc. | 9.0× |
| HNGE Hinge Health Inc. compare | 12.7× |
| HTFL Heartflow, Inc. compare | 21.3× |
| Health Information Services industry median | 1.8× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement